{"article_title": "Docs, Drugmakers Call Medicare Pay Experiment Unlawful", "article_keywords": ["b", "attacks", "docs", "unlawful", "unlawfullaw360", "project", "experiment", "medicare", "york", "pay", "test", "drugmakers", "came", "view"], "article_url": "http://www.law360.com/articles/790372/docs-drugmakers-call-medicare-pay-experiment-unlawful", "article_text": "Docs, Drugmakers Call Medicare Pay Experiment Unlawful\n\nLaw360, New York (May 9, 2016, 8:35 PM ET) -- Doctors and drugmakers launched intense attacks Monday on a controversial proposal to overhaul drug payments in Medicare Part B, accusing regulators of overstepping their powers.\n\n\n\nThe criticism came as a deadline passed Monday to comment on a major pilot project floated in March by the Centers for Medicare and Medicaid Services. The project would test alternative reimbursement models under Part B, which spends $20 billion annually on prescription drugs, often pricey injectables for serious diseases.\n\n\n\nSome of the fiercest attacks came from the Community Oncology Alliance,...\n\nTo view the full article, register now.", "article_metadata": {"description": "Doctors and drugmakers launched intense attacks Monday on a controversial proposal to overhaul drug payments in Medicare Part B, accusing regulators of overstepping their powers.", "apple-itunes-app": "app-id=934560389, app-argument=law360://www.law360.com/articles/790372/docs-drugmakers-call-medicare-pay-experiment-unlawful", "csrf-token": "JifVPHHiMSglVVvjtV7xV6t3gt26e2QOvUOjzfEpXd8PTQrYROmT9ftkARFNEadGWK28oGdGcX0aAkUQBQU6Fw==", "csrf-param": "authenticity_token", "og": {"url": "http://www.law360.com/articles/790372/docs-drugmakers-call-medicare-pay-experiment-unlawful", "image": "https://www.law360.com/images/360.png", "type": "website", "title": "Docs, Drugmakers Call Medicare Pay Experiment Unlawful - Law360"}, "viewport": "width=device-width, initial-scale=1.0"}, "article_summary": "Docs, Drugmakers Call Medicare Pay Experiment UnlawfulLaw360, New York (May 9, 2016, 8:35 PM ET) -- Doctors and drugmakers launched intense attacks Monday on a controversial proposal to overhaul drug payments in Medicare Part B, accusing regulators of overstepping their powers.\nSome of the fiercest attacks came from the Community Oncology Alliance,...To view the full article, register now.\nThe criticism came as a deadline passed Monday to comment on a major pilot project floated in March by the Centers for Medicare and Medicaid Services.\nThe project would test alternative reimbursement models under Part B, which spends $20 billion annually on prescription drugs, often pricey injectables for serious diseases."}